These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7756716)

  • 21. The effect of recombinant human erythropoietin in treating the anemia of prematurity.
    Wang TS; Lee CC; Deng HH; Lin JT; Chang JS; Lin ST
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):121-7. PubMed ID: 7793277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enteral administration of recombinant erythropoietin to preterm infants.
    Britton JR; Christensen RD
    J Perinatol; 1995; 15(4):281-3. PubMed ID: 8558334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of erythropoietin in neonates.
    Ohls RK
    Clin Perinatol; 2000 Sep; 27(3):681-96. PubMed ID: 10986635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.
    Maier RF; Obladen M; Müller-Hansen I; Kattner E; Merz U; Arlettaz R; Groneck P; Hammer H; Kössel H; Verellen G; Stock GJ; Lacaze-Masmonteil T; Claris O; Wagner M; Matis J; Gilberg F;
    J Pediatr; 2002 Jul; 141(1):8-15. PubMed ID: 12091844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
    Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
    An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of recombinant human erythropoietin in the treatment of anaemia of prematurity.
    Polkowska G; Wójcik-Skierucha E; Furmaga-Jabłońska W
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):178-83. PubMed ID: 16146073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey on clinical use and non-use of recombinant human erythropoietin in European neonatal units.
    Bolte K; Maier RF
    J Perinat Med; 2020 Sep; 48(7):744-750. PubMed ID: 32681780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteral granulocyte-colony stimulating factor and erythropoietin early in life improves feeding tolerance in preterm infants: a randomized controlled trial.
    El-Ganzoury MM; Awad HA; El-Farrash RA; El-Gammasy TM; Ismail EA; Mohamed HE; Suliman SM
    J Pediatr; 2014 Dec; 165(6):1140-1145.e1. PubMed ID: 25155966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron status and the treatment of the anemia of prematurity.
    Kling PJ; Winzerling JJ
    Clin Perinatol; 2002 Jun; 29(2):283-94. PubMed ID: 12168242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical use of erythropoietin].
    Franchini M; Gandini G; Lippi G; De Gironcoli M; Cantini M; Aprili G
    Recenti Prog Med; 2004 Mar; 95(3):129-36; quiz 185. PubMed ID: 15143948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model.
    Suk KK; Dunbar JA; Liu A; Daher NS; Leng CK; Leng JK; Lim P; Weller S; Fayard E
    J AAPOS; 2008 Jun; 12(3):233-8. PubMed ID: 18589385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, placebo-controlled clinical trial of recombinant human erythropoietin in the anemia of prematurity.
    Mentzer WC; Shannon KM; Abels RI; Freeman P; Newton N; Thompson D; Phibbs RH
    Contrib Nephrol; 1991; 88():306-12; discussion 313. PubMed ID: 2040193
    [No Abstract]   [Full Text] [Related]  

  • 35. Low doses of recombinant erythropoietin in the treatment of anaemia of prematurity.
    Latini G; Rosati E; Del Vecchio A
    Acta Paediatr; 2001 Jul; 90(7):825-6. PubMed ID: 11519992
    [No Abstract]   [Full Text] [Related]  

  • 36. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity".
    Christensen RD
    Pediatrics; 1989 May; 83(5):793-6. PubMed ID: 2717299
    [No Abstract]   [Full Text] [Related]  

  • 37. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
    Dallman PR
    Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea.
    Strauss RG
    J Pediatr; 1997 Nov; 131(5):653-5. PubMed ID: 9403639
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dosing with recombinant human erythropoietin, used for treating early anemia of premature infants].
    Rabbani F
    Lik Sprava; 2002; (3-4):81-4. PubMed ID: 12145901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.